With the analysis among 510 patents, we discovered top 65 key players by total patent application. CRISPR Therapeutics AG, Seagen Inc., eTheRNA immunotherapies NV are dominant in this area. They take 29.41% of the total patent filing.
Massachusetts, United States
Patent: 59
Washington, United States
Patent: 50
eTheRNA immunotherapies NV
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 41
New York, United States
Patent: 34
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 25
California, United States
Patent: 22
New Jersey, United States
Patent: 21
California, United States
Patent: 21
With the analysis among 13 patents, we discovered top 4 start-ups by total patent application. ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd, Institut National de la Santé et de la Recherche Médicale, Suzhou Kerui Gene Biotechnology Co. Ltd. are active in this area.
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 5
Institut National de la Santé et de la Recherche Médicale
Suzhou Kerui Gene Biotechnology Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 344 patents applied in the last 5 years. We discover 65 most active companies in this area. The fast-growing CRISPR Therapeutics AG, eTheRNA immunotherapies NV, Pfizer Inc. take 38.95% of patent filing during this period.
Massachusetts, United States
Patent: 59
eTheRNA immunotherapies NV
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 41
New York, United States
Patent: 34
Bern, Switzerland
Patent: 26
The Board of Regents of The University of Texas System
Texas, United States
Patent: 18
Zhejiang Sheng, China
Patent: 10
California, United States
Patent: 8
Massachusetts, United States
Patent: 8
California, United States
Patent: 7
With the analysis among related 344 patents in last 5 years, we discover 48 new entrants. CRISPR Therapeutics AG, eTheRNA immunotherapies NV, Pfizer Inc. are the most active new entrants in this area.
Massachusetts, United States
Patent: 59
eTheRNA immunotherapies NV
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 41
New York, United States
Patent: 34
The Board of Regents of The University of Texas System
Texas, United States
Patent: 18
Zhejiang Sheng, China
Patent: 10
California, United States
Patent: 8
Massachusetts, United States
Patent: 8
California, United States
Patent: 7
Nanjing Blue Shield Biotech Co., Ltd.
Chongqing Precision Biotech Co., Ltd
Chongqing Shi, China
Patent: 6
With the analysis among 119 patents, we discovered top 16 universities and scientific research institutions by total patent application. University of Bern, Baylor College of Medicine, Vrije Universiteit Brussel are dominant in this area. They take 53.78% of the total patent filing.
Bern, Switzerland
Patent: 28
Baylor College of Medicine
Texas, United States
Patent: 18
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 15
Birmingham, United Kingdom
Patent: 6
Regents of the University of Colorado
Colorado, United States
Patent: 5
The Johns Hopkins University
Université de Paris 5 René Descartes
National University of Singapore
Central Region, Singapore
Patent: 1
Hunan Sheng, China
Patent: 1
Guangdong Sheng, China
Patent: 1